Newly diagnosed diabetes mellitus as a risk factor for serious liver disease - PubMed (original) (raw)
. 2010 Aug 10;182(11):E526-31.
doi: 10.1503/cmaj.092144. Epub 2010 Jun 21.
Affiliations
- PMID: 20566726
- PMCID: PMC2917963
- DOI: 10.1503/cmaj.092144
Newly diagnosed diabetes mellitus as a risk factor for serious liver disease
Liane Porepa et al. CMAJ. 2010.
Abstract
Background: The negative impact of diabetes mellitus is well recognized, yet little is known about the effect of this disease on the liver, an organ susceptible to nonalcoholic fatty liver disease related to insulin resistance. We evaluated whether adults with newly diagnosed diabetes were at increased risk of serious liver disease.
Methods: We used administrative health databases for the province of Ontario (1994-2006) to perform a population-based matched retrospective cohort study. The exposed group comprised 438 069 adults with newly diagnosed diabetes. The unexposed comparison group--those without known diabetes--consisted of 2 059 708 individuals, matched 5:1 to exposed persons, by birth year, sex and local health region. We excluded individuals with pre-existing liver or alcohol-related disease. The primary study outcome was the subsequent development of serious liver disease, namely, liver cirrhosis, liver failure and its sequelae, or receipt of a liver transplant.
Results: The incidence rate of serious liver disease was 8.19 per 10 000 person-years among those with newly diagnosed diabetes and 4.17 per 10 000 person-years among those without diabetes. The unadjusted hazard ratio was 1.92 (95% confidence interval [CI] 1.83-2.01). After adjustment for age, income, urban residence, health care utilization and pre-existing hypertension, dyslipidemia, obesity and cardiovascular disease, the hazard ratio was 1.77 (95% CI 1.68-1.86).
Interpretation: Adults with newly diagnosed diabetes appeared to be at higher risk of advanced liver disease, also known as diabetic hepatopathy. Whether this reflects nonalcoholic fatty liver disease or direct glycemic injury of the liver remains to be determined.
Figures
Figure 1
Risk of serious liver disease according to participants’ characteristics at study entry, comparing those with newly diagnosed diabetes mellitus and matched individuals without diabetes mellitus. Hazard ratios (HRs) were adjusted for age (continuous, in years); income quintile; urban residence; presence of hypertension, dyslipidemia, obesity or cardiovascular disease within 36 months before study entry; number of hospital admissions within 36 months before study entry; and number of primary care visits within 12 months before study entry. With the exception of the age stratum, adjustment was not performed on the variable being stratified. CI = confidence interval.
Comment in
- Early warning of liver disease in diabetics.
Arab JP, Ramírez C, Arrese M. Arab JP, et al. Ann Hepatol. 2010 Jul-Sep;9(3):307-9. Ann Hepatol. 2010. PMID: 20720278 No abstract available. - Diabetes mellitis: risk factor for advanced liver disease.
Siddiqi F, Carter L, Peltekian KM. Siddiqi F, et al. CMAJ. 2011 Mar 22;183(5):586. doi: 10.1503/cmaj.111-2029. CMAJ. 2011. PMID: 21422147 Free PMC article. No abstract available.
Similar articles
- Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population.
Yang S, Kwak S, Lee JH, Kang S, Lee SP. Yang S, et al. PLoS One. 2019 Nov 4;14(11):e0224626. doi: 10.1371/journal.pone.0224626. eCollection 2019. PLoS One. 2019. PMID: 31682638 Free PMC article. - Prevalence and risk factors of fatty liver in Portuguese adults.
Leitão J, Carvalhana S, Cochicho J, Silva AP, Velasco F, Medeiros I, Alves AC, Bourbon M, Oliveiros B, Rodrigues V, Sousa R, Sampaio F, Carvalho A, Cortez-Pinto H. Leitão J, et al. Eur J Clin Invest. 2020 Jun;50(6):e13235. doi: 10.1111/eci.13235. Epub 2020 May 19. Eur J Clin Invest. 2020. PMID: 32289180 - Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver.
Sung KC, Lee MY, Kim YH, Huh JH, Kim JY, Wild SH, Byrne CD. Sung KC, et al. Atherosclerosis. 2018 Aug;275:50-57. doi: 10.1016/j.atherosclerosis.2018.05.042. Epub 2018 May 24. Atherosclerosis. 2018. PMID: 29860108 - Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
Younossi ZM, Marchesini G, Pinto-Cortez H, Petta S. Younossi ZM, et al. Transplantation. 2019 Jan;103(1):22-27. doi: 10.1097/TP.0000000000002484. Transplantation. 2019. PMID: 30335697 Review. - Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease.
Rubinstein E, Lavine JE, Schwimmer JB. Rubinstein E, et al. Semin Liver Dis. 2008 Nov;28(4):380-5. doi: 10.1055/s-0028-1091982. Epub 2008 Oct 27. Semin Liver Dis. 2008. PMID: 18956294 Review.
Cited by
- Olive Oil's Attenuating Effects on Lipotoxicity.
Basheer M, Bolus M, Basheer A, Loai A, Nimer A. Basheer M, et al. Adv Exp Med Biol. 2024;1460:869-882. doi: 10.1007/978-3-031-63657-8_29. Adv Exp Med Biol. 2024. PMID: 39287875 Review. - The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in individuals living with diabetes.
Ma X, Zhu Y, Yeo YH, Fan Z, Xu X, Rui F, Ni W, Gu Q, Tong X, Yin S, Qi X, Shi J, Wu C, Li J. Ma X, et al. Hepatol Int. 2024 Jun;18(3):952-963. doi: 10.1007/s12072-023-10625-7. Epub 2024 Jan 22. Hepatol Int. 2024. PMID: 38252365 - Liver injury in COVID-19 patients with non-alcoholic fatty liver disease: an update.
Miranda C, Garlatti E, Da Porto A, Rinaldo E, Grazioli S, Zanette G, Tonizzo M. Miranda C, et al. Arch Med Sci Atheroscler Dis. 2023 Feb 23;8:e1-e10. doi: 10.5114/amsad/160950. eCollection 2023. Arch Med Sci Atheroscler Dis. 2023. PMID: 37153375 Free PMC article. - Fatty liver index as a predictor for incident type 2 diabetes in community-dwelling adults: longitudinal findings over 12 years.
Seo IH, Lee HS, Lee YJ. Seo IH, et al. Cardiovasc Diabetol. 2022 Oct 13;21(1):209. doi: 10.1186/s12933-022-01642-1. Cardiovasc Diabetol. 2022. PMID: 36229839 Free PMC article. - The Association of Salt Intake and Non-alcoholic Fatty Liver Disease in People With Type 2 Diabetes: A Cross-Sectional Study.
Takahashi F, Hashimoto Y, Kaji A, Sakai R, Kawate Y, Okamura T, Kitagawa N, Okada H, Nakanishi N, Majima S, Osaka T, Senmaru T, Ushigome E, Hamaguchi M, Fukui M. Takahashi F, et al. Front Nutr. 2022 Jul 13;9:943790. doi: 10.3389/fnut.2022.943790. eCollection 2022. Front Nutr. 2022. PMID: 35911124 Free PMC article.
References
- Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–9. - PubMed
- Lipscombe LL, Hux JE. Trend in diabetes prevalence, incidence, and mortality in Ontario, Canada (1995–2005): a population-based study. Lancet. 2007;369:750–6. - PubMed
- Booth GL, Kapral MK, Fung K, et al. Relation between age and cardiovascular disease in men and women with diabetes compared with nondiabetic people: a population-based retrospective cohort study. Lancet. 2006;368:29–36. - PubMed
- Youssef W, McCullough AJ. Diabetes mellitus, obesity, and hepatic steatosis. Semin Gastrointest Dis. 2002;13:17–30. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical